GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ortivus AB (OSTO:ORTI B) » Definitions » EV-to-FCF

Ortivus AB (OSTO:ORTI B) EV-to-FCF : -5.60 (As of Dec. 13, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Ortivus AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ortivus AB's Enterprise Value is kr113.22 Mil. Ortivus AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was kr-20.23 Mil. Therefore, Ortivus AB's EV-to-FCF for today is -5.60.

The historical rank and industry rank for Ortivus AB's EV-to-FCF or its related term are showing as below:

OSTO:ORTI B' s EV-to-FCF Range Over the Past 10 Years
Min: -917.42   Med: -10.18   Max: 292.54
Current: -5.6

During the past 13 years, the highest EV-to-FCF of Ortivus AB was 292.54. The lowest was -917.42. And the median was -10.18.

OSTO:ORTI B's EV-to-FCF is ranked worse than
100% of 374 companies
in the Medical Devices & Instruments industry
Industry Median: 28.73 vs OSTO:ORTI B: -5.60

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-13), Ortivus AB's stock price is kr1.72. Ortivus AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was kr-0.400. Therefore, Ortivus AB's PE Ratio (TTM) for today is At Loss.


Ortivus AB EV-to-FCF Historical Data

The historical data trend for Ortivus AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortivus AB EV-to-FCF Chart

Ortivus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.51 12.49 197.39 -22.09 -19.36

Ortivus AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 259.71 -19.36 -22.89 -20.65 -8.71

Competitive Comparison of Ortivus AB's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Ortivus AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortivus AB's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ortivus AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Ortivus AB's EV-to-FCF falls into.



Ortivus AB EV-to-FCF Calculation

Ortivus AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=113.219/-20.227
=-5.60

Ortivus AB's current Enterprise Value is kr113.22 Mil.
Ortivus AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-20.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ortivus AB  (OSTO:ORTI B) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Ortivus AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.72/-0.400
=At Loss

Ortivus AB's share price for today is kr1.72.
Ortivus AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.400.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Ortivus AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Ortivus AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortivus AB Business Description

Traded in Other Exchanges
Address
Karlsrovagen 2D, Box 713, Danderyd, Stockholm, SWE, 182 17
Ortivus AB is a supplier of mobile solutions for modern emergency medical care. Its product portfolio includes MobiMed Smart and CoroNet.

Ortivus AB Headlines

No Headlines